Postprostatectomy Ultrasound-guided Transrectal Implantation of Gold Markers for External Beam Radiotherapy. Technique and Complications Rate

Overview

Journal Strahlenther Onkol

Specialties Oncology
Radiology

Date 2013 Apr 23

PMID 23604186

Citations 6

Authors

J F Langenhuijsen

R Donker

G M McColl

L A L M Kiemeney

J A Witjes

E N J T van Lin

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Postprostatectomy radiotherapy (RT) improves survival in adjuvant and salvage settings. The implantation technique and complications rate of gold markers in the prostate bed for high-precision RT were analyzed.

Patients And Methods: Patients undergoing postprostatectomy RT for prostate-specific antigen (PSA) relapse or high-risk disease were enrolled in the study. Under transrectal ultrasound guidance, three fine gold markers were implanted in the prostate bed and the technical difficulties of insertion were documented. Patients received our self-designed questionnaires concerning complications and pain. The influence of anticoagulants and coumarins on bleeding was analyzed, as was the effect of potential risk factors on pain.

Results: In 77 consecutive patients, failure of marker implantation or marker migration was seen in six cases. Rectal bleeding was reported by 10 patients and 1 had voiding complaints. No macroscopic hematuria persisting for more than 3 days was observed. Other complications included rectal discomfort (n = 2), nausea (n = 1), abdominal discomfort (n = 1), and pain requiring analgesics (n = 4). No major complications were reported. On a 0-10 visual analogue scale (VAS), the mean pain score was 3.7. No clinically significant risk factors for complications were identified.

Conclusion: Transrectal implantation of gold markers in the prostate bed is feasible and safe. Alternatives like cone beam computed tomography (CBCT) should be considered, but the advantages of gold marker implantation for high-precision postprostatectomy RT would seem to outweigh the minor risks involved.

Citing Articles

Exploratory models comparing ethiodized oil-glue and gold fiducials for bladder radiotherapy image-guidance.

Joon D, Berlangieri A, Harris B, Tacey M, OMeara R, Pitt B Phys Imaging Radiat Oncol. 2021; 17:77-83.

PMID: 33898783 PMC: 8058020. DOI: 10.1016/j.phro.2021.01.008.

Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept.

Vilotte F, Antoine M, Bobin M, Latorzeff I, Supiot S, Richaud P Front Oncol. 2017; 7:34.

PMID: 28337425 PMC: 5343009. DOI: 10.3389/fonc.2017.00034.

Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer : A single institution, prospective study.

Jorgo K, Agoston P, Major T, Takacsi-Nagy Z, Polgar C Strahlenther Onkol. 2017; 193(6):452-458.

PMID: 28154882 DOI: 10.1007/s00066-017-1104-2.

Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?.

Murray J, McNair H, Dearnaley D Cancer Manag Res. 2015; 7:331-44.

PMID: 26635484 PMC: 4646477. DOI: 10.2147/CMAR.S51955.

Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.

Song C, Kang H, Kim J, Eom K, Kim I, Chung J Strahlenther Onkol. 2015; 191(10):801-9.

PMID: 26159555 DOI: 10.1007/s00066-015-0872-9.

References

Henry A, Wilkinson C, Wylie J, Logue J, Price P, Khoo V . Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: an assessment of procedure related morbidity, patient acceptability and accuracy. Radiother Oncol. 2004; 73(1):57-9. DOI: 10.1016/j.radonc.2004.08.007. View

Langenhuijsen J, van Lin E, Kiemeney L, van der Vight L, McColl G, Visser A . Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors. Int J Radiat Oncol Biol Phys. 2007; 69(3):671-6. DOI: 10.1016/j.ijrobp.2007.04.009. View

Peeters S, Heemsbergen W, Koper P, van Putten W, Slot A, Dielwart M . Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol. 2006; 24(13):1990-6. DOI: 10.1200/JCO.2005.05.2530. View

Piziorska M, Kukolowicz P, Zawadzka A, Pilichowska M, Peczkowski P . Adaptive off-line protocol for prostate external radiotherapy with cone beam computer tomography. Strahlenther Onkol. 2012; 188(11):1003-9. DOI: 10.1007/s00066-012-0226-9. View

Kupelian P, Langen K, Willoughby T, Wagner T, Zeidan O, Meeks S . Daily variations in the position of the prostate bed in patients with prostate cancer receiving postoperative external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2006; 66(2):593-6. DOI: 10.1016/j.ijrobp.2006.05.071. View

Wu J, Haycocks T, Alasti H, Ottewell G, Middlemiss N, Abdolell M . Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol. 2001; 61(2):127-33. DOI: 10.1016/s0167-8140(01)00452-2. View

Van Den Heuvel F, Fugazzi J, Seppi E, Forman J . Clinical application of a repositioning scheme, using gold markers and electronic portal imaging. Radiother Oncol. 2006; 79(1):94-100. DOI: 10.1016/j.radonc.2006.03.002. View

Bottke D, Bartkowiak D, Schrader M, Wiegel T . Radiotherapy after radical prostatectomy: immediate or early delayed?. Strahlenther Onkol. 2012; 188(12):1096-101. DOI: 10.1007/s00066-012-0234-9. View

Zelefsky M, Levin E, Hunt M, Yamada Y, Shippy A, Jackson A . Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008; 70(4):1124-9. DOI: 10.1016/j.ijrobp.2007.11.044. View

10.

Langen K, Jones D . Organ motion and its management. Int J Radiat Oncol Biol Phys. 2001; 50(1):265-78. DOI: 10.1016/s0360-3016(01)01453-5. View

11.

Pinkawa M, Siluschek J, Gagel B, Piroth M, Demirel C, Asadpour B . Postoperative radiotherapy for prostate cancer : evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy). Strahlenther Onkol. 2007; 183(1):23-9. DOI: 10.1007/s00066-007-1588-2. View

12.

Ghadjar P, Gwerder N, Madlung A, Behrensmeier F, Thalmann G, Mini R . Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer. Strahlenther Onkol. 2009; 185(11):731-5. DOI: 10.1007/s00066-009-2007-7. View

13.

Thompson I, Tangen C, Paradelo J, Lucia M, Miller G, Troyer D . Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009; 181(3):956-62. PMC: 3510761. DOI: 10.1016/j.juro.2008.11.032. View

14.

Sandhu A, Sethi R, Rice R, Wang J, Marcus L, Salem C . Prostate bed localization with image-guided approach using on-board imaging: reporting acute toxicity and implications for radiation therapy planning following prostatectomy. Radiother Oncol. 2008; 88(1):20-5. DOI: 10.1016/j.radonc.2008.05.009. View

15.

Bylund K, Bayouth J, Smith M, Hass A, Bhatia S, Buatti J . Analysis of interfraction prostate motion using megavoltage cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2008; 72(3):949-56. DOI: 10.1016/j.ijrobp.2008.07.002. View

16.

Dehnad H, Nederveen A, van der Heide U, Jeroen A van Moorselaar R, Hofman P, Lagendijk J . Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol. 2003; 67(3):295-302. DOI: 10.1016/s0167-8140(03)00078-1. View

17.

Park R, Martin S, Goldberg J, Lepor H . Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence. Urology. 2001; 57(4):742-6. DOI: 10.1016/s0090-4295(00)01048-7. View

18.

Stephenson A, Scardino P, Kattan M, Pisansky T, Slawin K, Klein E . Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007; 25(15):2035-41. PMC: 2670394. DOI: 10.1200/JCO.2006.08.9607. View

19.

Schiffner D, Gottschalk A, Lometti M, Aubin M, Pouliot J, Speight J . Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007; 67(2):610-9. DOI: 10.1016/j.ijrobp.2006.09.042. View

20.

Surya B, Provet J, Johanson K, Brown J . Anastomotic strictures following radical prostatectomy: risk factors and management. J Urol. 1990; 143(4):755-8. DOI: 10.1016/s0022-5347(17)40082-6. View